Endpoint Welcomes Richard Schroeder and Launches Two Isolated-Organ Training Programs
Endpoint Welcomes Richard Schroeder and Launches Two Isolated-Organ Training Programs
Endpoint Preclinical is pleased to welcome Richard Schroeder, BS, RVT, LAT to our Expert Network and announce the launch of two new on-site training programs in isolated perfused heart and kidney techniques.
Richard brings more than 40 years of experience in preclinical drug discovery and experimental physiology, with extensive expertise in developing and optimizing isolated-organ models across pharma, biotech, and CRO environments. His work spans cardiovascular and renal physiology, model development, functional assessment, and advanced data interpretation.
Through these new programs, research teams can work directly with Richard to establish isolated-organ capabilities, expand existing applications, and develop the technical and physiological understanding needed to generate reliable functional data.
Bringing Specialized Expertise into the Laboratory
Both programs are delivered on-site and can support laboratories establishing a new isolated-organ capability or refining an existing one. Beyond procedural instruction, Richard brings the experimental physiology and model-development expertise needed to help research teams apply these techniques to their own scientific objectives.





